+419.2%
NVDA vs THC
+265.6%
+153.7%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.1% | +1.9% | -6.0% | -4.7% |
| 7D | -12.6% | +0.9% | -13.5% | -12.8% |
| 30D | -27.1% | +9.1% | -36.2% | -29.1% |
| 3M | -30.6% | +8.8% | -39.4% | -32.7% |
| 6M | -30.5% | +48.2% | -78.8% | -39.5% |
| YTD | -16.1% | +46.7% | -62.8% | -27.5% |
| 1Y | -17.7% | +51.1% | -68.8% | -29.8% |
| 3Y | +216.5% | +401.4% | -184.9% | +54.8% |
| 5Y | +419.2% | +265.8% | +153.4% | +186.7% |
| All | +419.2% | +265.6% | +153.7% | +186.7% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling